SkyePharma PLC Company Profile (LON:SKP)

About SkyePharma PLC

SkyePharma PLC logoSkyepharma Ltd, formerly Skyepharma PLC, is a drug delivery company engaged in the development of oral and inhalation products. The Company operates as an independent developer of complex pharmaceutical products for global markets. Its principal activities are the generation and development of product and drug delivery technology concepts, involving the application of its inhalation and oral technologies. It operates through the segment of development and supply of pharmaceutical products. It is also involved in the supply of products to its marketing partners, as in the case for flutiform and over seven oral products manufactured in its Lyon Facility. It operates primarily for respiratory applications. Its inhalation products include Relvar Ellipta/Breo Ellipta, Anoro Ellipta and Incruse Ellipta. Its oral products include RAYOS/LODOTRA, Requip Once-a-day, Xatral/Uroxatral, Madopar DR/Prolopa, Sular, ZYFLO CR, Paxil CR, Diclofenacratiopharm Uno, Triglide and Coruno.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: SKP
  • CUSIP:
Key Metrics:
  • Previous Close: $5.80
  • 50 Day Moving Average: $466.10
  • 200 Day Moving Average: $407.95
  • 52-Week Range: GBX 249.25 - GBX 486.25
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for SkyePharma PLC (LON:SKP) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 407.50

Analysts' Ratings History for SkyePharma PLC (LON:SKP)
Show:
DateFirmActionRatingPrice TargetDetails
2/17/2016Stifel NicolausReiterated RatingBuyGBX 460View Rating Details
1/28/2016N+1 SingerReiterated RatingCorporateView Rating Details
1/22/2016FinnCapReiterated RatingBuyView Rating Details
12/23/2015RX SecuritiesReiterated RatingBuyView Rating Details
1/19/2015Oriel Securities LtdReiterated RatingBuyView Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for SkyePharma PLC (LON:SKP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for SkyePharma PLC (LON:SKP)
Current Year EPS Consensus Estimate: $19.75 EPS

Dividends

Dividend History for SkyePharma PLC (LON:SKP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for SkyePharma PLC (LON:SKP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/29/2016Derodra,AndrewInsiderBuy32GBX 473£151.36
3/31/2016Derodra,AndrewInsiderBuy33GBX 449£148.17
1/2/2016Grant,PeterInsiderBuy46GBX 327£150.42
11/30/2015Derodra,AndrewInsiderBuy46GBX 327£150.42
11/4/2015Grant,PeterInsiderBuy47GBX 322£151.34
10/30/2015Derodra,AndrewInsiderBuy47GBX 322£151.34
10/5/2015Grant,PeterInsiderBuy42GBX 354£148.68
9/4/2015Derodra,AndrewInsiderBuy48GBX 312£149.76
8/4/2015Grant,PeterInsiderBuy54GBX 279£150.66
7/3/2015Derodra,AndrewInsiderBuy55GBX 273£150.15
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for SkyePharma PLC (LON:SKP)
DateHeadline
trustnet.com logoVectura Group plc (VEC) (LON:SKP)
www.trustnet.com - September 7 at 7:26 PM
publicnow.com logoUpdate on Mundipharma’s European Phase III trial of flutiform® in COPD and latest flutiform® in-market sales (LON:SKP)
www.publicnow.com - August 30 at 10:40 AM
sg.finance.yahoo.com logoVectura's therapy misses primary goal in late stage lung disease trial (LON:SKP)
sg.finance.yahoo.com - August 30 at 10:40 AM
publicnow.com logoUS$8 million Exparel® sales milestone from Pacira (LON:SKP)
www.publicnow.com - August 5 at 10:28 AM
publicnow.com logoUS$8 million Exparel® sales milestone from Pacira triggered (LON:SKP)
www.publicnow.com - August 5 at 10:28 AM
publicnow.com logoVectura initiates legal proceedings against GSK relating to option-to-licence patent agreement and confirms 2016 revenue guidance (LON:SKP)
www.publicnow.com - July 27 at 12:58 PM
publicnow.com logoVectura initiates legal proceedings against GSK (LON:SKP)
www.publicnow.com - July 27 at 12:28 PM
capitalcube.com logoETF’s with exposure to Vectura Group Plc : July 18, 2016 (LON:SKP)
www.capitalcube.com - July 18 at 2:28 PM
News IconHow Many SkyePharma PLC (LON:SKP)'s Analysts Are Bullish? - Consumer Eagle (LON:SKP)
www.consumereagle.com - July 17 at 11:29 AM
ftsenews.co.uk logoSkyepharma (LON:SKP) New Price Targets - FTSE News (LON:SKP)
www.ftsenews.co.uk - July 13 at 10:21 AM
News IconToday's pharma leaders are less experienced in other sectors, but does it matter? - The Pharma Letter (registration) (LON:SKP)
www.thepharmaletter.com - July 13 at 10:21 AM
publicnow.com logoTransaction Notification (LON:SKP)
www.publicnow.com - July 8 at 6:01 AM
publicnow.com logoBoard Committee changes post completion of merger with Skyepharma (LON:SKP)
www.publicnow.com - July 7 at 5:31 AM
fiscalstandard.com logoSkyepharma (LON:SKP) Broker Updates - Fiscal Standard (LON:SKP)
www.fiscalstandard.com - July 6 at 12:03 PM
publicnow.com logoBoard Committee changes (LON:SKP)
www.publicnow.com - July 5 at 9:01 AM
4-traders.com logoVectura : Lyon manufacturing facility returns to the Vectura Group (LON:SKP)
www.4-traders.com - July 1 at 7:25 PM
fiscalstandard.com logoSkyepharma (LON:SKP) Broker Roundup - Fiscal Standard (LON:SKP)
www.fiscalstandard.com - June 30 at 7:41 PM
4-traders.com logoHBM Healthcare Investments : Recommended all share merger of Skyepharma and Vectura becomes effective (LON:SKP)
www.4-traders.com - June 11 at 7:37 PM
publicnow.com logoNotification of Major Intrest in Shares (LON:SKP)
www.publicnow.com - June 10 at 1:29 PM
publicnow.com logoRecommended all share merger of Skyepharma and Vectura becomes effective (LON:SKP)
www.publicnow.com - June 10 at 11:39 AM
publicnow.com logoCompany Act 2006 S430 (2B) Disclosure (LON:SKP)
www.publicnow.com - June 10 at 8:29 AM
publicnow.com logoForm 8.5 (EPT/RI) - Skyepharma PLC Amendment (LON:SKP)
www.publicnow.com - June 8 at 8:08 AM
publicnow.com logoTechnology License Agreement (LON:SKP)
www.publicnow.com - June 7 at 10:38 AM
News IconSkyepharma (LON:SKP) Morning Trade Volumes - Share Trading News (LON:SKP)
www.sharetrading.news - June 2 at 7:55 PM
uk.finance.yahoo.com logo'I'm looking for stocks that will double in three years - and here's what I'm backing' - Yahoo Finance UK (LON:SKP)
uk.finance.yahoo.com - June 2 at 10:33 AM
uk.finance.yahoo.com logo'I'm looking for stocks that will double in three years - and here's what I'm backing' (LON:SKP)
uk.finance.yahoo.com - June 2 at 8:25 AM
publicnow.com logoForm 8.3 - Skypepharma PLC (LON:SKP)
www.publicnow.com - June 1 at 10:43 AM
News IconVectura all set for SkyePharma merger - Investors Chronicle (LON:SKP)
www.investorschronicle.co.uk - May 31 at 7:47 PM
News IconAnalyst Coverage Updates - Skyepharma (LON:SKP) - Risers & Fallers (LON:SKP)
www.risersandfallers.com - April 9 at 2:48 PM
capitalcube.com logoSkyePharma Plc :SKP-GB: Earnings Analysis: For the six months ended December 31, 2015 (LON:SKP)
www.capitalcube.com - April 7 at 12:29 PM
uk.finance.yahoo.com logoForm 8.3 - Skyepharma Plc (LON:SKP)
uk.finance.yahoo.com - April 6 at 10:00 AM
uk.finance.yahoo.com logoVectura receives support from Skyepharma shareholder (LON:SKP)
uk.finance.yahoo.com - March 17 at 7:55 AM
uk.finance.yahoo.com logoSkyepharma and Vectura agree merger; Skyepharma swings to profit (LON:SKP)
uk.finance.yahoo.com - March 16 at 9:47 AM
uk.finance.yahoo.com logoIs Fast-Growing Skyepharma PLC Better than Vodafone Group plc? (LON:SKP)
uk.finance.yahoo.com - March 16 at 8:57 AM
uk.finance.yahoo.com logoVectura to buy SkyePharma for $620 mln as UK biotech consolidates (LON:SKP)
uk.finance.yahoo.com - March 16 at 8:26 AM
capitalcube.com logoSkyePharma Plc : Neutral outlook but great fundamentals (LON:SKP)
www.capitalcube.com - March 11 at 4:08 PM
capitalcube.com logoSkyePharma Plc breached its 50 day moving average in a Bearish Manner : SKP-GB : March 7, 2016 (LON:SKP)
www.capitalcube.com - March 7 at 4:36 AM
News IconAre Analysts Bearish SkyePharma PLC (LON:SKP) After Last Week? - RiversideGazette.com (LON:SKP)
www.riversidegazette.com - February 28 at 2:30 PM
News IconSkyepharma (LON:SKP) Recent Analyst Updates - Risers & Fallers (LON:SKP)
www.risersandfallers.com - February 26 at 9:44 AM
capitalcube.com logoSkyePharma Plc breached its 50 day moving average in a Bullish Manner : SKP-GB : February 26, 2016 (LON:SKP)
www.capitalcube.com - February 26 at 4:33 AM
uk.finance.yahoo.com logoShould You Ditch GlaxoSmithKline plc And Buy Vectura Group PLC And SkyePharma PLC? - Yahoo Finance UK (LON:SKP)
uk.finance.yahoo.com - February 23 at 2:59 PM
money.aol.co.uk logoShould You Ditch GlaxoSmithKline plc And Buy Vectura Group PLC And SkyePharma PLC? - AOL Money UK (LON:SKP)
money.aol.co.uk - February 22 at 2:55 PM
News IconAre Analysts Bullish SkyePharma PLC (LON:SKP) After Last Week? - RiversideGazette.com (LON:SKP)
www.riversidegazette.com - February 22 at 2:55 PM
News IconSkyePharma PLC (LON:SKP) Buy Rating Reconfirmed by Analysts at Stifel; The Price Objective is Set to GBX 460.00 - OctaFinance.com (LON:SKP)
www.octafinance.com - February 19 at 2:34 PM
News IconSkyePharma PLC (LON:SKP) Receives Buy Rating From Stifel Analysts - Risers & Fallers (LON:SKP)
www.risersandfallers.com - February 18 at 2:16 PM
biz.yahoo.com logoFull Year 2015 SkyePharma PLC Earnings Release - Time Not Supplied (LON:SKP)
biz.yahoo.com - February 16 at 7:07 AM
News IconRecent Broker Updates On Skyepharma (LON:SKP) - Risers & Fallers (LON:SKP)
www.risersandfallers.com - February 11 at 1:32 PM
News IconWhat Will Happen to SkyePharma PLC Next? The Stock Just Increased A Lot - Sonoran Weekly Review (LON:SKP)
sonoranweeklyreview.com - February 10 at 1:38 PM
News IconCould SkyePharma PLC Crash Even More? The Stock Had Another Big Decline Today - Sonoran Weekly Review (LON:SKP)
sonoranweeklyreview.com - February 9 at 1:04 PM
capitalcube.com logoSkyePharma Plc breached its 50 day moving average in a Bearish Manner : February 9, 2016 (LON:SKP)
www.capitalcube.com - February 9 at 4:35 AM

Social


Last Updated on 9/27/2016 by MarketBeat.com Staff